Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Chan

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 18, 1998
Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIAD M Lynch, P E Rogers, J C Love, et al.
Journal of Proteome Research|October 16, 2010
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assaysA Prakash, T Rezai, B Krastins, et al.
Clinical Chemistry|November 24, 2001
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassayP Stieber, R Molina, D W Chan, et al.
Oncogene|September 6, 2016
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signalingD W Chan, W W Y Hui, J J Wang, et al.
Journal of Clinical Laboratory Analysis|March 4, 1998
Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serumD L Morris, P W Dillon, D L Very, et al.
Wiener Klinische Wochenschrift|July 25, 1998
Elecsys CEA, PSA and AFP. Clinical results of a multicentre evaluationW Uhl, D W Chan, K Jones, et al.
Clinical Chemistry|October 3, 1999
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigenD W Chan, C A Kelley, T L Ratliff, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 18, 1998
Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIAD M Lynch, P E Rogers, J C Love, et al.
Journal of Proteome Research|October 16, 2010
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assaysA Prakash, T Rezai, B Krastins, et al.
Clinical Chemistry|November 24, 2001
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassayP Stieber, R Molina, D W Chan, et al.
Oncogene|September 6, 2016
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signalingD W Chan, W W Y Hui, J J Wang, et al.
Journal of Clinical Laboratory Analysis|March 4, 1998
Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serumD L Morris, P W Dillon, D L Very, et al.
Wiener Klinische Wochenschrift|July 25, 1998
Elecsys CEA, PSA and AFP. Clinical results of a multicentre evaluationW Uhl, D W Chan, K Jones, et al.
Clinical Chemistry|October 3, 1999
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigenD W Chan, C A Kelley, T L Ratliff, et al.
Pageof 17